TRAIL leads to apoptosis in acute promyelocytic leukaemia

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial

10.1046/j.1365-2141.2000.02442.x ◽

2000 ◽

Vol 111 (3) ◽

pp. 801-806 ◽

Cited By ~ 44

Author(s):

Stephane de Botton ◽

Sylvie Chevret ◽

Miguel Sanz ◽

Herve Dombret ◽

Xavier Thomas ◽

...

Keyword(s):

Additional Chromosomal Abnormalities

Poor Prognosis ◽

Chromosomal Abnormalities ◽

Promyelocytic Leukaemia ◽

Cytogenetic influence on prognosis in acute promyelocytic leukaemia: a cohort study in Vietnam

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2021.06.003 ◽

2021 ◽

Author(s):

Minh Phuong Vu ◽

Cuc Nhung Nguyen ◽

Hoang Vu

Keyword(s):

Cohort Study ◽

A novel HNRNPC‐RARA fusion in acute promyelocytic leukaemia lacking PML‐RARA rearrangement, sensitive to venetoclax‐based therapy

10.1111/bjh.17642 ◽

2021 ◽

Author(s):

Meng Liu ◽

Xiujie Zhao ◽

Wenjue Pan ◽

Zijun Qian ◽

Mengbao Du ◽

...

Keyword(s):

Rapidly progressing, fatal and acute promyelocytic leukaemia that initially manifested as a painful third molar: a case report

Journal of Medical Case Reports ◽

10.1186/1752-1947-3-102 ◽

2009 ◽

Vol 3 (1) ◽

Cited By ~ 2

Author(s):

Juan A Suárez-Cuenca ◽

José L Arellano-Sánchez ◽

Aldo A Scherling-Ocampo ◽

Gerardo Sánchez-Hernández ◽

David Pérez-Guevara ◽

...

Keyword(s):

Case Report ◽

Third Molar ◽

Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era

Frontiers in Oncology ◽

10.3389/fonc.2020.586004 ◽

2020 ◽

Vol 10 ◽

Cited By ~ 1

Author(s):

Zheng-Li Xu ◽

Xiao-Jun Huang

Keyword(s):

Promyelocytic Leukaemia ◽

Therapeutic Approaches

Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis

Pathology ◽

10.1016/j.pathol.2016.02.012 ◽

2016 ◽

Vol 48 (3) ◽

pp. 286-288 ◽

Cited By ~ 1

Author(s):

Muhajir Mohamed ◽

Harry J. Iland ◽

Sharad Sharma ◽

Shane G. Supple

Keyword(s):

Promyelocytic Leukaemia ◽

Atypical Presentation ◽

Marrow Fibrosis

A CASE OF ACUTE PROMYELOCYTIC LEUKAEMIA WITH ‘FAGGOT CELLS’EXHIBITING STRONG ALPHA-NAPHTHYLBUTYRATE ESTERASE ACTIVITY

10.1111/j.1365-2141.1988.tb04193.x ◽

1988 ◽

Vol 68 (1) ◽

pp. 138-139 ◽

Cited By ~ 2

Author(s):

Petr Lemež

Keyword(s):

Esterase Activity ◽

Advantage of induction therapy with all trans retinoic acid in acute promyelocytic leukaemia in a country with limited transfusion resources: A Malaysian experience

European Journal Of Haematology ◽

10.1111/j.1600-0609.1994.tb00196.x ◽

2009 ◽

Vol 53 (4) ◽

pp. 237-241 ◽

Cited By ~ 2

Author(s):

K. W. Leong ◽

J. J. Bosco ◽

A. Teh

Keyword(s):

Retinoic Acid ◽

Induction Therapy ◽

Promyelocytic Leukaemia ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid

Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy

10.1111/bjh.12775 ◽

2014 ◽

Vol 165 (4) ◽

pp. 497-503 ◽

Cited By ~ 26

Author(s):

Steven E. Coutre ◽

Megan Othus ◽

Bayard Powell ◽

Cheryl L. Willman ◽

Wendy Stock ◽

...

Keyword(s):

Maintenance Therapy ◽

Arsenic Trioxide ◽

Promyelocytic Leukaemia ◽

Intermediate Risk

Acute promyelocytic leukaemia associated Factor XIII deficiency presenting as retro-bulbar haematoma

Thrombosis Research ◽

10.1016/j.thromres.2012.03.008 ◽

2012 ◽

Vol 129 (6) ◽

pp. 810-811 ◽

Cited By ~ 3

Author(s):

Elias Gonçalves ◽

Rodrigo Lopes da Silva ◽

Joaquim Varandas ◽

Maria João Diniz

Keyword(s):

Factor Xiii ◽

Promyelocytic Leukaemia ◽

Factor Xiii Deficiency ◽

Associated Factor